Heartflow CFO sells 24,345 shares in September

Q: Who is the insider involved in this Form 4 for HTFL and what is their role?

The Form 4 reports transactions by Vikram Verghese, who is the Chief Financial Officer of Heartflow, Inc. It covers his sales of Heartflow common stock in mid-September 2026.

Q: How many Heartflow (HTFL) shares did the CFO sell according to this Form 4?

The CFO reported selling a total of 24,345 shares of Heartflow common stock, consisting of 7,579 shares on September 17, 2026 and 16,766 shares on September 18, 2026.

Q: At what prices were the HTFL shares sold in the reported transactions?

On September 17, 2026, the CFO sold shares at a weighted average price of $50.1142. On September 18, 2026, he sold shares at a weighted average price of $50.7531. Each transaction was executed in multiple trades within disclosed price ranges.

Q: Does the Form 4 state how many HTFL shares the CFO holds after these sales?

No. The Form 4 entries list the shares sold in each transaction, but the fields for total shares following the transactions are not populated in this data.

Heartflow’s CFO reported 10b5-1 plan sales totaling 24,345 common shares over two days in September 2026.

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Heartflow, Inc. (HTFL) reported that its Chief Financial Officer, Vikram Verghese, sold shares of common stock in two open-market transactions made under a Rule 10b5-1 trading plan adopted on June 4, 2026. On September 17, 2026 he sold 7,579 shares at a weighted average price of $50.1142 per share, and on September 18, 2026 he sold 16,766 shares at a weighted average price of $50.7531, each sale executed in multiple trades within stated price ranges.

Insights

Analyzing...

Insider Trade Summary 10b5-1

Net Seller: 24,345 shares

Net Sell 2 txns

Insider Verghese Vikram

Role Chief Financial Officer

Sold 24,345 shs ($1.23M)

Type	Security	Shares	Price	Value
Sale	Common Stock. ^{F1, F3}	16,766	$50.7531	$851K
Sale	Common Stock. ^{F1, F2}	7,579	$50.1142	$380K

Holdings After Transaction: Common Stock. — 155,183 shares (Direct)

Footnotes (3)

F1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026.
F2. This transaction was executed in multiple trades at price ranging from $50.00 to $50.29. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3. This transaction was executed in multiple trades at price ranging from $50.00 to $52.11. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Shares sold September 17, 2026: 7,579 shares Weighted average sale price September 17, 2026: $50.1142 per share Shares sold September 18, 2026: 16,766 shares +3 more

6 metrics

Shares sold September 17, 2026 7,579 shares Sale of Heartflow common stock by CFO in an open-market or private transaction

Weighted average sale price September 17, 2026 $50.1142 per share Multiple trades executed in a range of $50.00 to $50.29

Shares sold September 18, 2026 16,766 shares Sale of Heartflow common stock by CFO in an open-market or private transaction

Weighted average sale price September 18, 2026 $50.7531 per share Multiple trades executed in a range of $50.00 to $52.11

Total shares sold 24,345 shares Aggregate of both reported sales transactions

Rule 10b5-1 trading plan adoption date June 4, 2026 Plan under which the reported sales were effected

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, open market or private transaction, common stock

4 terms

Rule 10b5-1 trading plan regulatory

"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"The price reported above reflects the weighted average sale price"

open market or private transaction financial

"Sale in open market or private transaction"

common stock financial

"Common Stock."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who is the insider involved in this Form 4 for HTFL and what is their role?

The Form 4 reports transactions by Vikram Verghese, who is the Chief Financial Officer of Heartflow, Inc. It covers his sales of Heartflow common stock in mid-September 2026.

How many Heartflow (HTFL) shares did the CFO sell according to this Form 4?

The CFO reported selling a total of 24,345 shares of Heartflow common stock, consisting of 7,579 shares on September 17, 2026 and 16,766 shares on September 18, 2026.

At what prices were the HTFL shares sold in the reported transactions?

On September 17, 2026, the CFO sold shares at a weighted average price of $50.1142. On September 18, 2026, he sold shares at a weighted average price of $50.7531. Each transaction was executed in multiple trades within disclosed price ranges.

Were the CFO’s HTFL stock sales made under a Rule 10b5-1 trading plan?

Yes. The filing states that the reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2026, indicating they were pre-arranged under that plan.

What price ranges applied to the CFO’s HTFL sales on each date?

For September 17, 2026, trades occurred in a price range of $50.00 to $50.29. For September 18, 2026, trades occurred in a price range of $50.00 to $52.11. The reported prices are weighted averages for each day.

Does the Form 4 state how many HTFL shares the CFO holds after these sales?

No. The Form 4 entries list the shares sold in each transaction, but the fields for total shares following the transactions are not populated in this data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 09/18/2026 - 08:47 PM Accepted by SEC EDGAR 09/18/2026 - 08:46 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Verghese Vikram

(Last)

(First)

(Middle)

C/O HEARTFLOW, INC.

135 MAIN STREET, SUITE 1000

(Street)

SAN FRANCISCO

CALIFORNIA

94105

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Heartflow, Inc. [ HTFL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock.	09/17/2026		S⁽¹⁾		7,579	D	$50.1142⁽²⁾	171,949	D
Common Stock.	09/18/2026		S⁽¹⁾		16,766	D	$50.7531⁽³⁾	155,183	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026.

2. This transaction was executed in multiple trades at price ranging from $50.00 to $50.29. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

3. This transaction was executed in multiple trades at price ranging from $50.00 to $52.11. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

	/s/ Nga Van, by power of attorney	09/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR